Cycliramine
- Level
- Commodity
- Parent
- 51313200
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313210This classification denotes a histamine-1 receptor antagonist with the molecular formula C18H19ClN2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N61YTN00CK, chemically known as 4-(p-chloro-.alpha.-2-pyridylbenzylidene)-1-methylpiperidine but generally known as cycliramine, which bears US NIH Compound Identifier 5357113. The term cycliramine is an International Non-Proprietary Name or INN. European Medicines Agency schedules cycliramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06846MIG. Most nations schedule cycliramine under HS 29333999 and SITC 51574. As of Q4 2014, CYCLIRAMINE remains the US FDA Preferred Term for this commodity. Cycliramine bears US NLM identifiers UMLS ID C2828319 and NCI Concept Code C87479. SMILES: CN1CCC(=C(C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CC1.C(=CC(=O)O)C(=O)O.
Same parent
Under 51313200 · 20Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.